$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which class of drugs does ensifentrine-Ohtuvayre belong to and its position and role in treatment?
2026-02-01 22:25:32
Check Details
Detailed explanation of the time required for treating acne with Roaccutane (isotretinoin) and the precautions for medication
2026-02-01 22:25:32
Check Details
Which class of antineoplastic drugs does Doxorubicin belong to? Pharmacological classification and clinical significance analysis
2026-02-01 22:25:32
Check Details
Safety matters and patient guidance that need to be paid attention to during the use of everolimus (Afinitor)
2026-02-01 22:25:32
Check Details
Is Estramustine covered by medical insurance? Medical insurance policies and reimbursement instructions
2026-02-01 22:25:32
Check Details
A comprehensive explanation of the patient safety and efficacy of seripalase (BRINEURA)
2026-02-01 22:25:32
Check Details
Eslicarbazepine explains in detail which types of epilepsy are most effective
2026-02-01 22:25:32
Check Details
Avatrombopag Medication Guide: Who should use it, how to use it, and how much it costs?
2026-02-01 22:25:32
Check Details
How effective is Gilteritinib in the treatment of acute myeloid leukemia? Full analysis of price, efficacy, and medication methods
2026-02-01 22:25:32
Check Details
What days are most likely to cause discomfort after taking Venetoclax/Venetoclax (Vekela) and how to relieve it
2026-02-01 22:25:32
Check Details
Summary of matters that need to be paid attention to while taking Asnib/Asiminib (Xinbeli)
2026-02-01 22:25:32
Check Details
Ritlecitinib generic drug prices and patient purchasing information
2026-02-01 22:25:32
Check Details
1
2
...
2225
2226
2227
2228
2229
2230
2231
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
2
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
3
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
4
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
5
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
6
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
7
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
8
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
9
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
10
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
11
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
12
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide